ret/PTC Activation Is Not Associated with Individual Radiation Dose Estimates in a Pilot Study of Neoplastic Thyroid Nodules Arising in Russian Children and Adults Exposed to Chernobyl Fallout
- 1 August 2008
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 18 (8) , 839-846
- https://doi.org/10.1089/thy.2008.0072
Abstract
Background: Ionizing radiation is the strongest risk factor known for the development of thyroid neoplasia. While previous studies have demonstrated a high prevalence of ret/papillary thyroid cancer (PTC) activation in cohorts of patients developing thyroid nodules after childhood exposure to ionizing radiation, no study has directly compared ret/PTC activation with individual estimates of radiation dose to the thyroid. This study combines individual thyroid dosimetry data with molecular analysis of surgically removed thyroid nodules in order to determine if ret/PTC activation in thyroid nodules is associated with increasing estimated radiation dose from Chernobyl. Methods: This pilot study included adults and children diagnosed with PTC (n = 76) and children diagnosed with follicular adenomas (n = 24) during May 1986 through December 1999, who were living in the Bryansk Oblast of the Russian Federation at the time of the Chernobyl accident, who had paraffin-embedded thyroid surgical samples available and for whom an individual dose to the thyroid could be estimated. The frequency of ret/PTC activation was determined using RT-PCR analysis. Individual radiation doses to the thyroid were estimated using a semiempirical model, and data were collected by detailed interview, primarily of the participant's mother. Results: ret/PTC oncogene activation was detected in 23.8% (5/21) and 14.5% (8/55) of the childhood and adult PTC cases, respectively, and 8.3% (2/24) of the follicular adenoma cases. No statistically significant differences were noted in age at the time of exposure or diagnosis, gender, latency period, or estimated radiation dose between PTC patients with or without ret/PTC activation. Further, no significant dose–response relationship was detected among PTC patients with ret/PTC activation. Conclusions: Factors other than individual thyroid radiation doses may influence the development and subsequent detection of ret/PTC oncogene activation in radiation related PTC arising in the Bryansk Oblast of the Russian Federation in the aftermath of the Chernobyl accident.Keywords
This publication has 38 references indexed in Scilit:
- Childhood Thyroid Cancer, Radiation Dose from Chernobyl, and Dose Uncertainties in Bryansk Oblast, Russia: A Population-Based Case-Control StudyRadiation Research, 2006
- Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinomaLaboratory Investigation, 2004
- Estimating individual thyroid doses for a case-control study of childhood thyroid cancer in Bryansk Oblast, RussiaRadiation Protection Dosimetry, 2004
- RET Expression in Papillary Thyroid Cancer from Patients Irradiated in Childhood for Benign ConditionsJournal of Clinical Endocrinology & Metabolism, 2002
- Preferential induction of RET/PTC1 rearrangement by X-ray irradiationOncogene, 2000
- Distinct frequency ofret rearrangements in papillary thyroid carcinomas of children and adults from BelarusInternational Journal of Cancer, 1999
- Low Prevalence of the ret/PTC3r1 Rearrangement in a Series of Papillary Thyroid Carcinomas Presenting in Belarus Ten Years Post-Chernoby1Thyroid®, 1998
- The ret/PTC1 Rearrangement is a Common Feature of Chernobyl-Associated Papillary Thyroid Carcinomas from BelarusThyroid®, 1998
- Expression of the RET/PTC Fusion Gene as a Marker for Papillary Carcinoma in Hashimoto's ThyroiditisThe Laryngoscope, 1997
- Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accidentThe Lancet, 1994